Colossal's claim to de-extinction sparks debate over authenticity
The American entrepreneur Ben Lamm's genetics startup Colossal Biosciences has made waves in 2025 by touting its ability to resurrect extinct species, including the dire wolf and woolly mammoth. However, scientists are questioning the legitimacy of these claims, pointing out that the company's efforts amount to little more than making genetic modifications to existing animals.
The dire wolf project, which was unveiled with great fanfare in April, saw Colossal claim to have revived the species through DNA tweaks. But experts say that instead of bringing back a new species, the company created 20 genetically modified grey wolves that bear some resemblance to dire wolves. The resulting animals do not substantially differ from those now roaming North America.
Similarly, the woolly mammoth project has been met with skepticism. While Colossal claims to be working on reviving the iconic species, its approach amounts to creating a genetically engineered Asian elephant adapted to live in cold climates, rather than truly bringing back the woolly mammoth.
Critics argue that these efforts are more like "poor copies" of extinct animals, created through genetic engineering and presented as the real deal. The company's harshest critics have even accused it of spreading misinformation and undermining trust in science by attacking those who question its claims.
Lamm, Colossal's chief scientist, has pushed back against these criticisms, arguing that his team is making progress and that "de-extinction" technology can help forge a future where populations are never at risk. However, many scientists disagree, pointing out that true de-extinction is not possible and that the company's efforts will never replace traditional conservation work.
While Colossal's harshest critics may be right to question its claims, it's also true that gene editing technology holds promise for saving species caught in genetic bottlenecks. The company's efforts to reintroduce lost genes into populations like the red wolf could potentially help restore biodiversity.
Ultimately, the debate over de-extinction highlights the need for a nuanced discussion about the role of science and technology in conservation. While gene editing may offer new tools for preserving species, it will never replace the time-consuming work of controlling predators, protecting ecosystems, and restoring habitats.
The American entrepreneur Ben Lamm's genetics startup Colossal Biosciences has made waves in 2025 by touting its ability to resurrect extinct species, including the dire wolf and woolly mammoth. However, scientists are questioning the legitimacy of these claims, pointing out that the company's efforts amount to little more than making genetic modifications to existing animals.
The dire wolf project, which was unveiled with great fanfare in April, saw Colossal claim to have revived the species through DNA tweaks. But experts say that instead of bringing back a new species, the company created 20 genetically modified grey wolves that bear some resemblance to dire wolves. The resulting animals do not substantially differ from those now roaming North America.
Similarly, the woolly mammoth project has been met with skepticism. While Colossal claims to be working on reviving the iconic species, its approach amounts to creating a genetically engineered Asian elephant adapted to live in cold climates, rather than truly bringing back the woolly mammoth.
Critics argue that these efforts are more like "poor copies" of extinct animals, created through genetic engineering and presented as the real deal. The company's harshest critics have even accused it of spreading misinformation and undermining trust in science by attacking those who question its claims.
Lamm, Colossal's chief scientist, has pushed back against these criticisms, arguing that his team is making progress and that "de-extinction" technology can help forge a future where populations are never at risk. However, many scientists disagree, pointing out that true de-extinction is not possible and that the company's efforts will never replace traditional conservation work.
While Colossal's harshest critics may be right to question its claims, it's also true that gene editing technology holds promise for saving species caught in genetic bottlenecks. The company's efforts to reintroduce lost genes into populations like the red wolf could potentially help restore biodiversity.
Ultimately, the debate over de-extinction highlights the need for a nuanced discussion about the role of science and technology in conservation. While gene editing may offer new tools for preserving species, it will never replace the time-consuming work of controlling predators, protecting ecosystems, and restoring habitats.